CA1055350A - Insufflator - Google Patents

Insufflator

Info

Publication number
CA1055350A
CA1055350A CA198,798A CA198798A CA1055350A CA 1055350 A CA1055350 A CA 1055350A CA 198798 A CA198798 A CA 198798A CA 1055350 A CA1055350 A CA 1055350A
Authority
CA
Canada
Prior art keywords
rotor
medicament
housing
capsule
chamber
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA198,798A
Other languages
French (fr)
Inventor
Roderick D. Elliott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Miles Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miles Laboratories Inc filed Critical Miles Laboratories Inc
Application granted granted Critical
Publication of CA1055350A publication Critical patent/CA1055350A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033Details of the piercing or cutting means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0091Inhalators mechanically breath-triggered
    • A61M15/0098Activated by exhalation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/06Solids
    • A61M2202/064Powder

Abstract

INSUFFLATOR
ABSTRACT

This invention relates to an inhalation device for dispensing medicament having a rotor-driven medicament dispenser. A unitary mouthpiece for both inhalation and exhalation communicates with a housing divided into two chambers by a rotor. One chamber has an outlet valve and the other chamber has an inlet valve. One side of the rotor has vanes attached thereto. The other side of the rotor has dispenser means for a medicament. Exhalation through the mouth-piece and through the outlet valve causes the vanes and the rotor to rotate. This motion disperses the medicament into its chamber.
Inhalation through the inlet valve and mouthpiece causes inhalation of the medicament to the patient.

Description

lOS5350 .. . .

SU~IMARY OF THE ~NVENTION . -Various insufflators have been proposed and used from which medicament can be inhaled directly into the lungs of a patient. These prior devices have generally relied upon the motion o the air being inhaled causing ~ ?
dispersion of the medicament into the air being inhaled.
Typical of such insufflators are devices described by Altounyan et al. in U.S. Patent Nos. 3,507,277 ~1970);
3,635;219 ~1972); and 3,669,113 ~1972).
lOIt has now been found that more reliable oPeration ~-of an insufflator can be obtained where the patient can `~
use the action of exhalation to distribute or disperse the medicament powder within a medicament chamber ready for reliable treatment upon inhalation drawing the dispersed powder from the chamber into the lungs of the patient.
According to the present invention there is provided an inhaling device for dispensing medicament in finely dlvided form comprising a housing, a rotor adapted to ..
~ . .

:

- . .. . . . . . ~ . :. ~ . . :

1~553so ~;
.:
disperse a medicament in a chamber within the housing, a mouthpiece communicating with the chamber, a passage communlcating between the chamber and the exterior of the housing, a drive portion of the rotor adapted to be driven by flow of air therepast, a second passage communicating the mouthpiece with the drive portion of the rotor, and ;
valve means permitting flow of air from the mouthpiece past said drive portion upon exhalation into the mouth-piece and alternatively permitting air flow through said first mentioned passage and said chamber upon inhalation through the mouthpiece.
Preferably the drive portion is provided in a - second chamber within the housing with the two chambers being separated by the rotor which may conveniently be in the form of a disk. The drive portion of the rotor ;
can then comprise a plurality of vanes adapted to be driven by an exhaled flow of air from the mouthpiece through the second chamber.
While the device may be constructed so as to provide on the rotor mounting means for a single capsule, prefer-ably so located as to extend radially outwards from the axis of the rotor so that when the outer end thereo-f is opened or pierced spinning of the rotor will help to dis-tribute medicament centrifugally within the medicament chamber, in an alternative arrangement a plurality of -~;
capsules may be mounted in a ring around the axis of the rotor with these capsules being usable in turn as ~
required by the patient. With this latter arrangement ~ ~ -conveniently the plurality of capsules may be mounted as part of a blister pack which is secured to a face of the rotor. It will be apparent that both capsule mounting arrangements provide means for effectively dispersing - lOSS~SO

medicament within the medicament chamber upon spinning of the rotor.
While it is possible for the capsules to be individ-ually opened or pierced as required by the patient before use by opening of the housing it is preferred that capsule opening means are provided selectively operable for breaking or piercing a capsule carried by the rotor. A
convenient form of capsule opening means may comprise a ~ ~
plunger manually movable between a rest position and the ~ -capsule opening position, the plunger being spring biased to a rest position. If a portion of the rotor iS
engageable from the outside o-E the housing for permitting indexing movement of the rotor within the housing, the rotor can readily be indexed to align a full capsule with the capsule opening means permitting the capsules in the insufflator to be prepared for use without any opening ;
of the housing by the patien~ being required. This is of particular convenience when the patient may require - ~
immediate relief, as all that he need do is take out the ` ~ :
loaded insufflator, open a capsule using the capsule .:. .
opening means, apply the mouthpiece to his mouth and quickly exhale before immediately inhaling to breath the ~;
dispersed particles of medicament into his lungs. .
A particularly convenient form of valve means com-prises nonreturn type flap valves covering ports through the housing, it being possible -for such flap valves to comprise simple flaps of resilient plastic material which I are normally in a position closing the ports associated f therewith.
f 30 BRIEF DESCRIPTION OF THE DRAWINGS

The i~vention will be further described, by way of example, with reference to the accompanying drawings, in which:

~L~553~
1 FIGURE 1 is a front elevational view of a single dose form of insufflator embodying the invention;
FIGURE 2 is a rear elevational view of the insuf-flator of Figure l;
FIGURE 3 is an end elevational view of the insuf-flator as viewed -from the right hand side of Figure l;
FIGURE 4 is a fragmentary sectional view taken through the front end cap of the insufflator and showing the inhalation nonreturn valve;
FIGURE 5 is a fragmentary sectional view taken through the rear end cap of the insufflator and showing the exhalation nonreturn valve; and FIGURE 6 to 8 are views similar to Figures l to 3 but showing a multiple dose form of the insufflator.
:.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
.
Referring to the drawings, and in particular to `~
Figures 1 to 3, there is shown a single dose inhalation device comprising a substantially cylindrical housing 1 of high impact thermosetting plastics material provided with front and rear end caps which, in the illustrated embodiment of the invention, are transparent. These end caps are screwed into position so as to be remo~able, and at least one of said end caps carries a bearing portion, not apparent in the drawings, for rotatably supporting a rotor 4 within the housing. The rotor is of disk like form and separates the chamber within the housing into a first chamber portion at the rear thereof and a second or medicament chamber portion at the front thereof. The rotor 4 comprises on the front side thereof a mounting 12 for a capsule or other suitable container 14 for accommodating ~J' ~ ~ ~ 53 a medicament to be dispensed, and on the rear side thereof is formed with a series of radial vanes 6 which, in a manner to be describecl below, acts as a drive por-tion for rotating the rotor. An inhalation passage or port 3 is provided through the end cap at the front of the housing, while an exhalation passage or port 5 is provided through the end cap at the rear o-f the housing. -A mouthpiece 2 has passage means which communicates with the interior o-f the housing and may comprise a divided entry providing a passage 11' leading to the aforementioned first chamber portion within the housing containing the ~ ;
vanes 6, and a passage 11 leading to the second or medi~
cament chamber portion within the housing within which , the rotor supports the medicament capsule 14. "
Manually operable capsule opening means 7 are shown ~
at the top of the housing as comprising a plunger 8 which ~ ;
is biased by a spring 9 to the rest position where an opening projection 10 is clear from contact with a cap-sule 14 carried by the rotor. The plunger 8 is manually ~ ;
depressable against the action of the spring 9 to cause the projection 10 to move towards the axis of the rotor whereby when a capsule 14 is aligned with the projection 10 such depression of the plunger will cause the projec-tion 10 to break or pierce the end of the capsule 14. ~ ;
Omitted in ~igures 1 and 2 are valve means in the form of nonreturn inhalation and exhalation valves 13 and 15 which cooperate with the ports 3 and 5, respectively.
These are shown in cross section in the detail views of Figures 4 and 5, the inhalation valve 13 being shown at the top of Figure 4 in the position closing the port 3 which it adopts at rest and when a patient is exha]ing through the mouthpiece 2 while the lower part of Pigure 4 ~ . . . -.. . .

1~553S0 shows the position adopted by the inhalation valve 13 when the patient is inhaling through the mouthpiece, air being sucked into the medicament chamber from the outside of the housing through the port 3. Similarly Figure 5 shows the exhalation valve 15 in its closed position which it occupies during rest and when the patient is inhaling through the mouthpiece and its open position which it occupies when the patient is exhaling through the mouthpiece.
In both instances the valves are simple nonreturn ~ , flap valves which are made of resilient plastic material ;
biased to closed position. The valve 13 is shown as mounted in a recess formed in an inner surface portion of the -front end cap of the housillg so that it does not project to a position where it could interfere with rota-tion of the rotor, while the valve 15 is shown as mounted on the outside of the rear end cap of the housing normally resiliently to close the port 5.
Figures 6 to 8 show an alternative embodiment of insufflator which is adapted to mount a plurality of cap-sules of medicament. The structure is generally similar ``
to that of Figures 1 to 3 with a housing 21 provided with a mouthpiece 22 and having in front and rear end caps, respectively, an inhalation port 23 and an exhalation port 25 provided with nonreturn flap valves similar to 'I those illustrated in Figures 4 and 5. A rotor 24 provided ¦ with vanes 26 on its rear side is mounted for rotation within the housing, the vanes being drivable by flow of air from the mouthpiece 22 through a first chamber portion 3~ containing the vanes and out through the exhalation port 25. On the front side of the disk like rotor a plurality of mounting means 32 are provided for capsules or other ;"
- .. .. ~ . ~ .. - -~ 55350 1 suitable containers 3~ for accommodating a medicament to be dispersed. The mounting means 32 are arranged to hold the capsules extending radially from the axis of the rotor, whereby upon rotation o~ the rotor a dispersion -of the medicament from a capsule will be assisted by centrifugal action, the outer end of the capsule being the part of the capsule opened.
In this embodiment no opening means corresponding `
with the opening means 7 of the first embodiment are illustrated although such may be provided if desired.
Instead, the user removes the front end cap of the housing in order manually to open a capsule before use of the insufflator, or he can use a piercing instrument to extend from the mouthpiece to penetrate the end of a capsule lS aligned with the mouthpiece passage 31.
As before, a portion of the rotor may be engageable exteriorly of the housing to permit indexing of a cap-sule for opening.
Instead of having individual mounting means for the various capsules they may be formed as a single blister pack which can be attached to the front face of the rotor 24.
In an alternative arrangement the rotor and medica-ment filled capsules may themselves comprise an entirely replaceable unit which can be provided within the housing for replacement by another full unit once all the individual doses have been used.
~uring use of the insufflator the patient, having loaded the device with one or more capsules, either opens one of the capsules manually be~ore replacing the end cover on the housing or utilizes an opening means 7 to .

~ ~ 5 5 3 S ~
l open the capsule after closure of the housing. The ~:
patient then puts the mouthpiece to his mouth and exhales strongly therethrough, whereupon the ai.r exhaled passes through the passage 11' or 30 into the -first chamber por~
tion within the housing flows past the vanes 6 or 26 and out through the exhalation port 5 or 25, causing the rotor - `
to spin at high speed to disperse medicament from the .
opened capsule into the medicament chamber portion within the housing. The patient then immediately inhales strongly through.the mouthpiece, wh.ereupon the ~alve 15 closes and the val~e 13 opens to permit air to be inhaled through inhalation port 3 or 23 and sai.d medicament chamber por~
tion, carrying with it medicament -from said chamber por~
tion lnto the Iungs of the patient, -8~ :
.', ~

,, , . . , ~ . . . .

Claims (9)

The embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows:
1. In a device for the inhalation of powdered medicament having a housing, a mouthpiece, a rotor, means for opening a capsule of medicament and means for dispersing the medicament in response to rotation of the rotor, the improvement comprising:
a first chamber portion and a medicament chamber portion in the housing respectively defined by one side of the rotor which carries a plurality of radial vanes to drive the rotor in response to air flow and by the other side of the rotor which carries one or more means for mounting medicament in capsule form;
air passage means in the mouthpiece respectively com-municating with the first chamber portion and with the medicament chamber portion of the housing;
an air exhaust port communicating with the first chamber portion and an air inlet port communicating with the medica-ment chamber portion; and first one-way valve means for enabling airflow through the first chamber portion and the exhaust port by exhalation through the mouthpiece and a second one-way valve means for enabling airflow through the inlet port and the medicament chamber to effect entrainment of the medicament by inhalation through the mouthpiece.
2. A device according to Claim 1 wherein said dispersing means comprises means on said rotor for mounting a plurality of capsules of medicament in spaced relation about the axis of said rotor.
3. Apparatus according to Claim 2 wherein said dispersing means comprises a replaceable unitary multiple capsule pack mounted on said rotor.
4. Apparatus according to Claim 2 wherein a plurality of capsules of medicament are mounted on said rotor and form therewith a replaceable unit.
5. A device according to Claim 1 wherein the capsule opening means comprises a plunger manually movable between a rest position and an operative position in which it is adapted to penetrate a capsule carried by said rotor.
6. A device according to Claim 5 wherein said plunger is spring biased toward its rest position.
7. Apparatus according to Claim 1 wherein said one-way valves are normally closed flap valves.
8. Apparatus according to Claim 1 wherein said air passage communicating with the first chamber is positioned to direct exhaled air at the drive portion of said rotor in a manner tending to cause rotation thereof.
9. A device according to Claim 1 wherein a portion of the rotor is engageable from outside of the housing for permitting indexing movement of the rotor within the housing.
CA198,798A 1973-05-08 1974-05-03 Insufflator Expired CA1055350A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2199173A GB1387954A (en) 1973-05-08 1973-05-08 Insufflator

Publications (1)

Publication Number Publication Date
CA1055350A true CA1055350A (en) 1979-05-29

Family

ID=10172161

Family Applications (1)

Application Number Title Priority Date Filing Date
CA198,798A Expired CA1055350A (en) 1973-05-08 1974-05-03 Insufflator

Country Status (14)

Country Link
US (1) US3870046A (en)
JP (1) JPS5048788A (en)
AR (1) AR198921A1 (en)
CA (1) CA1055350A (en)
CH (1) CH564950A5 (en)
DE (1) DE2421761C3 (en)
ES (1) ES426030A1 (en)
FR (1) FR2228499A1 (en)
GB (1) GB1387954A (en)
IL (1) IL44695A (en)
NL (1) NL7406119A (en)
NO (1) NO133923C (en)
SE (1) SE409547B (en)
ZA (1) ZA742561B (en)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2346914C3 (en) * 1973-09-18 1980-10-16 Paul Ritzau Pari-Werk, Gmbh & Co, 8130 Starnberg Powdered substance inhaler
SE408265B (en) * 1975-12-12 1979-06-05 Draco Ab DEVICE FOR CARBON DIOXIDE POWERED ENDOSAEROSOL, INTENDED FOR INHALATION
SE395611B (en) * 1975-12-12 1977-08-22 Draco Ab AEROSOL INHALATION DEVICE INTENDED FOR INHALATION THROUGH AN INHALATION MOUTH OF PHARMACOLOGICALLY ACTIVE SUBSTANCES
ES506585A0 (en) * 1980-10-30 1982-09-01 Riker Laboratories Inc A DEVICE TO FACILITATE THE ORAL INHALATION OF MEDICINES IN THE FORM OF POWDER
GB2169265B (en) * 1982-10-08 1987-08-12 Glaxo Group Ltd Pack for medicament
ZA837318B (en) * 1982-10-08 1985-06-26 Glaxo Group Ltd Device for administering medicaments to patients
CA1224992A (en) * 1982-10-08 1987-08-04 Robert E. Newell Device for administering medicament to patients
DE3348370C2 (en) * 1982-10-08 2001-10-11 Glaxo Group Ltd Hand-held inhaler for powder or liq. medical inhalants
US4570630A (en) * 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
FR2585563B1 (en) * 1985-07-30 1993-11-12 Glaxo Group Ltd DEVICE FOR ADMINISTERING MEDICINES TO PATIENTS
WO1988007855A1 (en) * 1987-04-09 1988-10-20 Fisons Plc Pharmaceutical compositions containing pentamidine
US5204113A (en) * 1987-04-09 1993-04-20 Fisons Plc Pharmaceutical compositions containing pentamidine
IT1222509B (en) * 1987-08-17 1990-09-05 Miat Spa INSUFFLATOR FOR THE ADMINISTRATION OF DRUGS IN THE FORM OF PRE-DOSED POWDER IN OPERATIONS
GB8804069D0 (en) * 1988-02-22 1988-03-23 Britains Petite Ltd Dispensers for powdered medication
IT1230313B (en) * 1989-07-07 1991-10-18 Somova Spa INHALER FOR CAPSULES MEDICATIONS.
DE3927170A1 (en) * 1989-08-17 1991-02-21 Boehringer Ingelheim Kg INHALATOR
YU48707B (en) * 1990-03-02 1999-07-28 Glaxo Group Limited Inhalation device
GB9004781D0 (en) * 1990-03-02 1990-04-25 Glaxo Group Ltd Device
US6536427B2 (en) 1990-03-02 2003-03-25 Glaxo Group Limited Inhalation device
SK280968B6 (en) * 1990-03-02 2000-10-09 Glaxo Group Limited Medicament pack for use in an inhalation device
GB9012870D0 (en) * 1990-06-08 1990-08-01 Glaxo Group Ltd Device
NZ238489A (en) * 1990-06-14 1995-09-26 Rhone Poulenc Rorer Ltd Inhaler with capsule in swirling chamber: capsule pierced in chamber
IT1243344B (en) * 1990-07-16 1994-06-10 Promo Pack Sa MULTI-DOSE INHALER FOR POWDER MEDICATIONS
US5797391A (en) * 1991-03-28 1998-08-25 Rhone-Poulenc Rorer Limited Inhaler
US5161524A (en) * 1991-08-02 1992-11-10 Glaxo Inc. Dosage inhalator with air flow velocity regulating means
GB2264237A (en) * 1992-02-05 1993-08-25 Robert Edward Newell An inhaler
US5476093A (en) * 1992-02-14 1995-12-19 Huhtamaki Oy Device for more effective pulverization of a powdered inhalation medicament
US5896855A (en) * 1992-12-24 1999-04-27 Rhone-Poulenc Rorer Limited Multi dose inhaler apparatus
NZ262807A (en) * 1993-03-03 1997-11-24 Glaxo Wellcome Inc Inhalator; medicament carrier for dry powder inhalator has a portion with a plurality of interstices, for a predetermined dose
US5372128A (en) * 1993-04-14 1994-12-13 Habley Medical Technology Corporation Fluidizing powder inhaler
US5388572A (en) * 1993-10-26 1995-02-14 Tenax Corporation (A Connecticut Corp.) Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
US5388573A (en) * 1993-12-02 1995-02-14 Tenax Corporation Dry powder inhalator medicament carrier
DE4400084C2 (en) * 1994-01-04 2001-08-02 Softec Gmbh & Co Kg Device for administering medication in solid form finely distributed in an air stream
IT1276916B1 (en) * 1995-10-12 1997-11-03 Istoria Farmaceutici S P A DEVICE FOR THE TREATMENT OF ASTHMATIC PATIENTS, ABLE TO MEASURE PEAK EXPIRATORY FLOW AND DELIVERY DRUGS FOR THE
US5669378A (en) * 1995-12-21 1997-09-23 Pera; Ivo Inhaling device
CA2212430A1 (en) 1997-08-07 1999-02-07 George Volgyesi Inhalation device
US6105929A (en) * 1997-11-14 2000-08-22 Salter Labs Control valve for gas supply to a nebulizer
GB9827370D0 (en) 1998-01-16 1999-02-03 Pari Gmbh Mouthpiece for inhalation therapy units
DE19831525A1 (en) * 1998-07-14 2000-01-20 Pfeiffer Erich Gmbh & Co Kg Media Donor
JP2003516200A (en) * 1999-12-07 2003-05-13 オリオン コーポレーション Multi-dose powder inhaler
DE19962110C2 (en) 1999-12-22 2003-06-12 Pari Gmbh Inhalation nebulizer with one-piece valve element
GB0201677D0 (en) 2002-01-25 2002-03-13 Glaxo Group Ltd Medicament dispenser
EP1467790A1 (en) * 2002-01-25 2004-10-20 Glaxo Group Limited Medicament dispenser
GB0317374D0 (en) 2003-07-24 2003-08-27 Glaxo Group Ltd Medicament dispenser
GB0325627D0 (en) * 2003-11-03 2003-12-10 Glaxo Group Ltd A hand-held capsule device
GB0418278D0 (en) 2004-08-16 2004-09-15 Glaxo Group Ltd Medicament dispenser
GB0515584D0 (en) 2005-07-28 2005-09-07 Glaxo Group Ltd Medicament dispenser
EP1993645A4 (en) * 2006-03-03 2011-05-18 Stc Unm Dry powder inhaler with aeroelastic dispersion mechanism
EP1844808A1 (en) * 2006-04-13 2007-10-17 BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG Medicament delivery device
GB0622827D0 (en) 2006-11-15 2006-12-27 Glaxo Group Ltd Sheet driver for use in a drug dispenser
WO2009046215A2 (en) * 2007-10-02 2009-04-09 Lab International Srl Safety and abuse deterrent improved device
CA2779488A1 (en) 2009-11-12 2011-05-19 Stc.Unm Dry powder inhaler with flutter dispersion member
ES2646748T3 (en) 2010-12-07 2017-12-15 Respira Therapeutics, Inc. Dry powder inhaler
FR2977498B1 (en) * 2011-07-05 2015-10-02 Valois Sas DRY POWDER INHALER.
US10463815B2 (en) 2012-02-21 2019-11-05 Respira Therapeutics, Inc. Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents
CN107427650A (en) 2015-01-14 2017-12-01 瑞必治公司 Powder process for dispersing and device

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1599959A (en) * 1923-03-23 1926-09-14 Fujimoto Buheiji Atomizer
US2573918A (en) * 1949-11-05 1951-11-06 Vick Chemical Company Device for dispensing medicaments
GB1268051A (en) * 1968-06-07 1972-03-22 Fisons Pharmaceuticals Ltd Inhalation device
IT941426B (en) * 1971-07-17 1973-03-01 Isf Spa SWIRL-CHAMBER INHALER FOR POWDER-SHAPING MEDICINAL SUBSTANCES
US3777742A (en) * 1972-09-18 1973-12-11 Barber Colman Co Tantalum insufflator

Also Published As

Publication number Publication date
AU6818374A (en) 1975-10-23
CH564950A5 (en) 1975-08-15
SE409547B (en) 1979-08-27
IL44695A0 (en) 1974-06-30
ZA742561B (en) 1975-04-30
ES426030A1 (en) 1976-07-01
NL7406119A (en) 1974-11-12
GB1387954A (en) 1975-03-19
US3870046A (en) 1975-03-11
NO133923B (en) 1976-04-12
IL44695A (en) 1977-01-31
DE2421761A1 (en) 1974-11-21
DE2421761B2 (en) 1977-08-18
JPS5048788A (en) 1975-05-01
DE2421761C3 (en) 1978-04-13
NO133923C (en) 1976-07-21
AR198921A1 (en) 1974-07-24
FR2228499A1 (en) 1974-12-06

Similar Documents

Publication Publication Date Title
CA1055350A (en) Insufflator
US5492112A (en) Dry powder inhaler
US5577497A (en) Dry powder inhaler
US6055980A (en) Dry powder inhaler
US5327883A (en) Apparatus for aerosolizing powdered medicine and process and using
US4627432A (en) Devices for administering medicaments to patients
JP5297719B2 (en) Deagglomeration device
US6116237A (en) Methods of dry powder inhalation
AU742962B2 (en) Inhalation apparatus for powder medications
GB2169265A (en) Pack for medicament
PH26882A (en) Devices for administering medicaments to patients
JPH08103499A (en) Inhalation type medicine administrator
IL108121A (en) Dry powder medicine inhaler
IE56060B1 (en) Medicament-containing pack